Showing results (1171-1180 of 1,884) with videos related to
Sort By:
Pageof 189
The Journal of Cell Biology|February 7, 2001
Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondiiM Reiss, N Viebig, S Brecht, et al.Journal of Hazardous Materials|May 31, 2011
Destruction and formation of PCDD/Fs in a fluidised bed combustor co-incinerating automotive shredder residue with refuse derived fuel and wastewater treatment sludgeJ Van Caneghem, I Vermeulen, C Block, et al.Journal of Psychoactive Drugs|December 9, 2010
Improving the accountability of California's public substance abuse treatment system through the implementation of performance modelsRichard A Rawson, Rachel Gonzales, Desirée Crèvecoeur-MacPhail, et al.Zeitschrift Fur Rheumatologie|March 3, 2004
[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany]P K Schädlich, H Zeidler, A Zink, et al.Protein Engineering, Design & Selection : PEDS|August 6, 2015
An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligationDuy Tien Ta, Erik Steen Redeker, Brecht Billen, et al.Dalton Transactions (Cambridge, England : 2003)|September 16, 2017
Grafting of a Eu3+-tfac complex on to a Tb3+-metal organic framework for use as a ratiometric thermometerAnna M Kaczmarek, Ying-Ya Liu, Chunhua Wang, et al.Frontiers in Plant Science|December 8, 2018
A Thermotolerant Variant of Rubisco Activase From a Wild Relative Improves Growth and Seed Yield in Rice Under Heat StressAndrew P Scafaro, Brian J Atwell, Steven Muylaert, et al.Plastic and Reconstructive Surgery|October 2, 2008
Nasoalveolar molding improves appearance of children with bilateral cleft lip-cleft palateCatherine T H Lee, Judah S Garfinkle, Stephen M Warren, et al.Pharmacoeconomics|April 28, 2005
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costsPeter K Schädlich, Henning Zeidler, Angela Zink, et al.Pharmacoeconomics|April 28, 2005
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiencyPeter K Schädlich, Henning Zeidler, Angela Zink, et al.Pageof 189